-
05.16.22 || A synthetic biology approach to address the immunosuppressive tumor microenvironment: novel TGF-β switch receptors convert inhibitory signals into enhanced NK cell activity
ASGCT 2022 Poster presentation
Read More -
05.16.22 || Engineered Allogeneic Car-Natural Killer Cells Resist Tumor Microenvironment Immuno-Suppression By Expression Of A Tgfbr2 Dominant Negative Receptor
ASGCT 2022 Poster presentation
Read More -
04.08.22 || Allogeneic natural killer cells engineered to express HER2 CAR, interleukin 15, and TGF-beta dominant negative receptor effectively control HER2+ tumors
AACR 2022 Poster Presentation
Read More -
12.11.21 || Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies
ASH 2021 Poster Presentation
Read More -
10.06.21 || Cryopreservation of Natural Killer and anti-CD19 Chimeric Antigen Receptor Natural Killer Cells
BMES 2021 Poster Presentation
Read More